A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,122 shares of HCM stock, worth $20,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,122
Previous 926 21.17%
Holding current value
$20,196
Previous $15,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$16.03 - $20.31 $3,141 - $3,980
196 Added 21.17%
1,122 $21,000
Q2 2024

Jul 30, 2024

BUY
$16.36 - $21.78 $15,149 - $20,168
926 New
926 $15,000
Q4 2022

Feb 09, 2023

SELL
$7.65 - $15.51 $66,256 - $134,332
-8,661 Reduced 3.28%
255,559 $3.78 Million
Q3 2022

Nov 10, 2022

BUY
$8.63 - $15.52 $967,569 - $1.74 Million
112,117 Added 73.71%
264,220 $2.34 Million
Q2 2022

Jul 26, 2022

SELL
$8.59 - $20.77 $98,742 - $238,751
-11,495 Reduced 7.03%
152,103 $1.92 Million
Q1 2022

May 10, 2022

BUY
$15.52 - $35.65 $873,900 - $2.01 Million
56,308 Added 52.48%
163,598 $3.1 Million
Q4 2021

Feb 08, 2022

SELL
$28.89 - $35.33 $598,629 - $732,072
-20,721 Reduced 16.19%
107,290 $3.76 Million
Q3 2021

Nov 15, 2021

SELL
$35.66 - $42.94 $445,856 - $536,878
-12,503 Reduced 8.9%
128,011 $4.69 Million
Q2 2021

Aug 11, 2021

SELL
$23.7 - $39.27 $39,318 - $65,148
-1,659 Reduced 1.17%
140,514 $5.52 Million
Q1 2021

May 13, 2021

BUY
$27.01 - $36.8 $516,917 - $704,278
19,138 Added 15.55%
142,173 $4.02 Million
Q4 2020

Feb 10, 2021

BUY
$27.51 - $34.36 $166,297 - $207,706
6,045 Added 5.17%
123,035 $3.94 Million
Q3 2020

Nov 12, 2020

SELL
$25.8 - $34.61 $1.35 Million - $1.81 Million
-52,341 Reduced 30.91%
116,990 $3.78 Million
Q2 2020

Aug 11, 2020

BUY
$17.65 - $28.05 $10,784 - $17,138
611 Added 0.36%
169,331 $4.67 Million
Q1 2020

May 12, 2020

SELL
$15.19 - $29.51 $273,693 - $531,711
-18,018 Reduced 9.65%
168,720 $3.01 Million
Q4 2019

Feb 12, 2020

SELL
$17.17 - $25.95 $95,465 - $144,282
-5,560 Reduced 2.89%
186,738 $4.68 Million
Q3 2019

Nov 12, 2019

BUY
$17.84 - $22.69 $3.43 Million - $4.36 Million
192,298 New
192,298 $3.43 Million
Q2 2019

Aug 13, 2019

SELL
$22.0 - $31.78 $196,856 - $284,367
-8,948 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$21.27 - $30.58 $190,323 - $273,629
8,948 New
8,948 $274,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.